$STEP
StepStone Group Inc. Stock $step

$step Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000179602222000029 Filed on May 31, 2022

Income Statement

Concept	2022 Q1	2022	2021 Q1
Revenue	$349.5M	$1.366B	$360.4M
YoY Change	-3.02%	73.35%	150.45%
Cost Of Revenue	$89.84M	$404.1M	$144.6M
YoY Change	-37.87%	64.25%	248.44%
Gross Profit	$259.7M	$952.9M	$215.8M
YoY Change	20.34%	74.2%	110.74%
Gross Profit Margin	74.3%	69.78%	59.88%
Selling, General & Admin	$90.22M	$294.9M	$59.72M
YoY Change	51.06%	41.8%	19.2%
% of Gross Profit	34.74%	30.95%	27.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.69M	$26.98M	$1.295M
YoY Change	802.55%	390.94%	-19.06%
% of Gross Profit	4.5%	2.83%	0.6%
Operating Expenses	$183.5M	$509.1M	$60.52M
YoY Change	203.14%	138.42%	18.21%
Operating Profit	$76.22M	$443.9M	$155.3M
YoY Change	-50.91%	33.09%	203.27%
Interest Expense	$20.02M	$1.113M	$8.634M
YoY Change	131.85%	-84.88%	979.25%
% of Operating Profit	26.26%	0.25%	5.56%
Other Income/Expense, Net	$19.61M	$60.22M	-$1.041M
YoY Change	-1983.48%	522.1%	48.71%
Pretax Income	$115.8M	$512.6M	$162.9M
YoY Change	-28.87%	51.72%	216.24%
Income Tax	$12.24M	$28.30M	$11.67M
% Of Pretax Income	10.56%	5.52%	7.17%
Net Earnings	$41.82M	$193.9M	$37.85M
YoY Change	10.49%	209.55%	-19.48%
Net Earnings / Revenue	11.96%	14.2%	10.5%
Basic Earnings Per Share		$3.89
Diluted Earnings Per Share	$652.9K	$3.84	$399.2K
COMMON SHARES
Basic Shares Outstanding		49.83M shares
Diluted Shares Outstanding		53.60M shares

Balance Sheet

Concept	2022 Q1	2022	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$116.4M	$116.4M	$179.9M
YoY Change	-35.3%	-35.3%	100.1%
Cash & Equivalents	$116.4M	$116.4M	$179.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$34.14M	$34.14M	$32.10M
Other Receivables	$2.834B	$2.834B	$904.0M
Total Short-Term Assets	$2.985B	$2.985B	$1.116B
YoY Change	167.48%	167.48%	90.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.76M	$73.83M	$10.23M
YoY Change	24.76%	621.74%	-6.64%
Goodwill	$580.5M		$6.800M
YoY Change	8436.76%		0.0%
Intangibles	$398.1M		$5.491M
YoY Change	7150.52%		-37.81%
Long-Term Investments	$2.922B	$107.0M	$970.9M
YoY Change	200.97%	43.92%	88.81%
Other Assets	$28.93M	$28.93M	$93.42M
YoY Change	-69.03%	-69.03%	13245.14%
Total Long-Term Assets	$1.203B	$1.203B	$204.8M
YoY Change	487.49%	487.49%	114.83%
TOTAL ASSETS
Total Short-Term Assets	$2.985B	$2.985B	$1.116B
Total Long-Term Assets	$1.203B	$1.203B	$204.8M
Total Assets	$4.188B	$4.188B	$1.321B
YoY Change	217.1%	217.1%	93.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.54M	$61.54M	$33.82M
YoY Change	81.95%	81.95%	-6.05%
Accrued Expenses	$2.021B	$2.021B	$499.8M
YoY Change	304.34%	304.34%	91.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.282B	$2.282B	$647.2M
YoY Change	252.59%	252.59%	115.37%
LONG-TERM LIABILITIES
Long-Term Debt	$62.88M	$62.88M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$19.00M	$19.00M	$13.90M
YoY Change	36.69%	36.69%
Total Long-Term Liabilities	$81.88M	$81.88M	$13.90M
YoY Change	489.06%	489.06%	-90.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.282B	$2.282B	$647.2M
Total Long-Term Liabilities	$81.88M	$81.88M	$13.90M
Total Liabilities	$2.364B	$3.371B	$661.1M
YoY Change	257.57%	214.6%	48.94%
SHAREHOLDERS EQUITY
Retained Earnings	$229.6M		$60.41M
YoY Change	280.11%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$817.6M	$817.6M	$249.4M
YoY Change
Total Liabilities & Shareholders Equity	$4.188B	$4.188B	$1.321B
YoY Change	217.1%	217.1%	93.99%

Cashflow Statement

Concept	2022 Q1	2022	2021 Q1
OPERATING ACTIVITIES
Net Income	$41.82M	$193.9M	$37.85M
YoY Change	10.49%	209.55%	-19.48%
Depreciation, Depletion And Amortization	$11.69M	$26.98M	$1.295M
YoY Change	802.55%	390.94%	-19.06%
Cash From Operating Activities	$32.30M	$214.3M	$29.00M
YoY Change	11.39%	43.52%	-1549.95%
INVESTING ACTIVITIES
Capital Expenditures	-$459.0K	$2.103M	-$258.0K
YoY Change	77.91%	67.17%	-57.0%
Acquisitions		$181.5M
YoY Change
Other Investing Activities	-$8.307M	-$35.00K	-$2.408M
YoY Change	244.98%	400.0%	50.5%
Cash From Investing Activities	-$8.766M	-$210.2M	-$2.666M
YoY Change	228.81%	1782.87%	21.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.37M	-$70.44M	-32.81M
YoY Change	32.19%	55.47%	49.8%
NET CHANGE
Cash From Operating Activities	32.30M	$214.3M	29.00M
Cash From Investing Activities	-8.766M	-$210.2M	-2.666M
Cash From Financing Activities	-43.37M	-$70.44M	-32.81M
Net Change In Cash	-19.83M	-$66.41M	-6.473M
YoY Change	206.33%	-170.71%	-75.2%
FREE CASH FLOW
Cash From Operating Activities	$32.30M	$214.3M	$29.00M
Capital Expenditures	-$459.0K	$2.103M	-$258.0K
Free Cash Flow	$32.76M	$212.2M	$29.26M
YoY Change	11.98%	43.32%	-2189.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001796022
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39510
CY2022	dei	Entity Registrant Name EntityRegistrantName	STEPSTONE GROUP INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3868757
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	450 Lexington Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	31st Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2022	dei	City Area Code CityAreaCode	212
CY2022	dei	Local Phone Number LocalPhoneNumber	351-6100
CY2022	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	STEP
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Public Float EntityPublicFloat	1760600000	USD
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, CA
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116386000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179886000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	1063000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	3977000	USD
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	34141000	USD
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	32096000	USD
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	19369000	USD
CY2021Q1	us-gaap	Due From Related Parties DueFromRelatedParties	7474000	USD
CY2022Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	107045000	USD
CY2021Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	74379000	USD
CY2022Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1480515000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	587243000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	188751000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	24715000	USD
CY2021Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	896523000	USD
CY2022Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	1334581000	USD
CY2021Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	0	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	27866000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	89439000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61065000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	27426000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398126000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5491000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	580542000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	6792000	USD
CY2022Q1	us-gaap	Assets Assets	4188125000	USD
CY2021Q1	us-gaap	Assets Assets	1320772000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	80541000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	659693000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	34224000	USD
CY2022Q1	step	Equity Method Investment Accrued Carried Interest Related Compensation Payable EquityMethodInvestmentAccruedCarriedInterestRelatedCompensationPayable	769988000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	229615000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	60407000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	658000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	155000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	817625000	USD
CY2021Q1	step	Equity Method Investment Accrued Carried Interest Related Compensation Payable EquityMethodInvestmentAccruedCarriedInterestRelatedCompensationPayable	465610000	USD
CY2022Q1	step	Legacy Investment Accrued Carried Interest Related Compensation Payable LegacyInvestmentAccruedCarriedInterestRelatedCompensationPayable	1140101000	USD
CY2021Q1	step	Legacy Investment Accrued Carried Interest Related Compensation Payable LegacyInvestmentAccruedCarriedInterestRelatedCompensationPayable	0	USD
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	199355000	USD
CY2021Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	47723000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	39966000	USD
CY2021Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	113522000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	70965000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	62879000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2363795000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	661079000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	249408000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1824330000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4188125000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1320772000	USD
CY2022	us-gaap	Revenues Revenues	1365525000	USD
CY2021	us-gaap	Revenues Revenues	787716000	USD
CY2020	us-gaap	Revenues Revenues	446611000	USD
CY2022	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	197482000	USD
CY2021	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	157123000	USD
CY2020	step	Compensation Expense Cash Based Compensation And Benefits CompensationExpenseCashBasedCompensationAndBenefits	130730000	USD
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13996000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7899000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1915000	USD
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	91208000	USD
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	30532000	USD
CY2020	step	Performance Fee Related Compensation Related To Carried Interest Allocation Realized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationRealized	26958000	USD
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	312903000	USD
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	215508000	USD
CY2020	step	Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocationUnrealized	82701000	USD
CY2022	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	404111000	USD
CY2021	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	246040000	USD
CY2020	step	Performance Fee Related Compensation Related To Carried Interest Allocation PerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	109659000	USD
CY2022	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	187106000	USD
CY2021	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	0	USD
CY2020	step	Legacy Performance Fee Related Compensation Related To Carried Interest Allocation LegacyPerformanceFeeRelatedCompensationRelatedToCarriedInterestAllocation	0	USD
CY2022	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	802695000	USD
CY2021	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	411062000	USD
CY2020	step	Compensation And Benefits Expense CompensationAndBenefitsExpense	242304000	USD
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110468000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48485000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52363000	USD
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	913163000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	459547000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	294667000	USD
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26160000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16407000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6926000	USD
CY2022	step	Legacy Investment Income LegacyInvestmentIncome	32586000	USD
CY2021	step	Legacy Investment Income LegacyInvestmentIncome	0	USD
CY2020	step	Legacy Investment Income LegacyInvestmentIncome	0	USD
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	337000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	413000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1436000	USD
CY2022	us-gaap	Interest Expense InterestExpense	1113000	USD
CY2021	us-gaap	Interest Expense InterestExpense	7360000	USD
CY2020	us-gaap	Interest Expense InterestExpense	10211000	USD
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2249000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	220000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1355000	USD
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	60219000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9680000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3204000	USD
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	512581000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	337849000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148740000	USD
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28300000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23256000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3955000	USD
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	144785000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	193885000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	62634000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.89
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49833760	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29657805	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53600250	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33274804	shares
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	144785000	USD
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	329000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1619000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	145000	USD
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1365000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	244000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	356000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62752000	USD
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1694000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1375000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-211000	USD
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	485975000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	315968000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	144574000	USD
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	194334000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
CY2019Q1	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	145662000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	144785000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-211000	USD
CY2020	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	28000	USD
CY2020	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	1915000	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	110753000	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	110753000	USD
	us-gaap	Partners Capital Account Treasury Units Purchases PartnersCapitalAccountTreasuryUnitsPurchases	3308000	USD
CY2020	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	113052000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	52913000	USD
CY2020Q1	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	236967000	USD
	us-gaap	Profit Loss ProfitLoss	57693000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	685000	USD
	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	27000	USD
	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	725000	USD
	us-gaap	Partners Capital Account Sale Of Units PartnersCapitalAccountSaleOfUnits	3308000	USD
	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	63585000	USD
	step	Partners Capital Account Reallocation Between Controlling And Non Controlling Interest PartnersCapitalAccountReallocationBetweenControllingAndNonControllingInterest	0	USD
	step	Stockholders Equity Effect Of Reorganization StockholdersEquityEffectOfReorganization	0	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	337798000	USD
	step	Adjustments To Additional Paid In Capital Purchase Of Partnership Interests AdjustmentsToAdditionalPaidInCapitalPurchaseOfPartnershipInterests	127986000	USD
	us-gaap	Profit Loss ProfitLoss	256900000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	690000	USD
	step	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	2749000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7174000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	34091000	USD
	us-gaap	Dividends Dividends	2227000	USD
	step	Stock Issued During Period Value Exchange Of Securities And New Issues StockIssuedDuringPeriodValueExchangeOfSecuritiesAndNewIssues	-9000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	11221000	USD
	step	Partners Capital Account Reallocation Between Controlling And Non Controlling Interest PartnersCapitalAccountReallocationBetweenControllingAndNonControllingInterest	0	USD
	step	Adjustments To Additional Paid In Capital Deferred Tax Effect AdjustmentsToAdditionalPaidInCapitalDeferredTaxEffect	2596000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	659693000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	659693000	USD
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	USD
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1694000	USD
CY2022	step	Noncontrolling Interest Increase From Contributions NoncontrollingInterestIncreaseFromContributions	15161000	USD
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13996000	USD
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	118796000	USD
CY2022	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3046000	USD
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	24677000	USD
CY2022	us-gaap	Profit Loss ProfitLoss	484281000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	314593000	USD
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-9000	USD
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	158142000	USD
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	653000	USD
CY2022	step	Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfNoncontrollingInterest	0	USD
CY2022	step	Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange AdjustmentsToAdditionalPaidInCapitalDeferredTaxEffectOfExchange	55293000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1824330000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	144785000	USD
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26977000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5495000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7078000	USD
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	298000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2103000	USD
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	236000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3856000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	796000	USD
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13996000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7899000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1915000	USD
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	6216000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	15913000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	9600000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1608000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2000	USD
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3034000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-70000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1774000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6975000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	851000	USD
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	11490000	USD
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-2216000	USD
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	7379000	USD
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2091000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	69000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3717000	USD
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6636000	USD
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	9559000	USD
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2807000	USD
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7107000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11282000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7937000	USD
CY2022	step	Increase Decrease In Accrued Carried Interest Related Compensation Payable IncreaseDecreaseInAccruedCarriedInterestRelatedCompensationPayable	-8525000	USD
CY2021	step	Increase Decrease In Accrued Carried Interest Related Compensation Payable IncreaseDecreaseInAccruedCarriedInterestRelatedCompensationPayable	12365000	USD
CY2020	step	Increase Decrease In Accrued Carried Interest Related Compensation Payable IncreaseDecreaseInAccruedCarriedInterestRelatedCompensationPayable	1974000	USD
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-2259000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1258000	USD
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	872000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-1511000	USD
CY2022	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	-413000	USD
CY2021	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	0	USD
CY2020	step	Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities IncreaseDecreaseInLeaseRightOfUseAssetsNetOfLeaseLiabilities	0	USD
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	214281000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	149299000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	65930000	USD
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	27694000	USD
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	71345000	USD
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	181529000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35809000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	837000	USD
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-35000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-7000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-210241000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11166000	USD
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3308000	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	110753000	USD
CY2022	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	83000	USD
CY2021	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	2776000	USD
CY2020	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	28000	USD
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	337798000	USD
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	185000000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2356000	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3046000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	131294000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	107188000	USD
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1732000	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	10142000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	USD
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	147000000	USD
CY2020	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1500000	USD
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	120000000	USD
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23874000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2047000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2022	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	787000	USD
CY2021	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	0	USD
CY2020	step	Payments To Related Parties Tax Receivable Agreements PaymentsToRelatedPartiesTaxReceivableAgreements	0	USD
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-9000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1029000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1350000	USD
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70439000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-45306000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-52170000	USD
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1097000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-252000	USD
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66414000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	93924000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49317000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89939000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40622000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117449000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89939000	USD
CY2022	us-gaap	Interest Paid Net InterestPaidNet	829000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3491000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	9355000	USD
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	11688000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3413000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2776000	USD
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	5864000	USD
CY2022	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	803000	USD
CY2021	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	180000	USD
CY2020	step	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	0	USD
CY2022	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	-55293000	USD
CY2021	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	-2596000	USD
CY2020	step	Deferred Tax Effect From Exchange Of Units Net DeferredTaxEffectFromExchangeOfUnitsNet	0	USD
CY2022	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	0	USD
CY2021	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	1079000	USD
CY2020	step	Offering Costs Incurred But Not Yet Paid OfferingCostsIncurredButNotYetPaid	0	USD
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	79688000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2022	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	558598000	USD
CY2021	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	0	USD
CY2020	step	Stock Issued For Acquisitions StockIssuedForAcquisitions	0	USD
CY2022	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	135239000	USD
CY2021	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	0	USD
CY2020	step	Partnership Units Issued For Acquisition PartnershipUnitsIssuedForAcquisition	0	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116386000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179886000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89939000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	1063000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	3977000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117449000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	183863000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89939000	USD
CY2020Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	100	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management’s estimates and assumptions are based on historical experience and other factors, and these estimates and assumptions require management to exercise judgment in the process of applying the Company’s accounting policies. Factors that may affect or influence management’s estimates and assumptions could include expectations related to future events that management has deemed reasonable under the circumstances. Assumptions and estimates related to the valuation of investments, which directly affect carried interest allocations, carried interest related compensation, and the carrying amount of the Company’s equity in affiliated companies, involve a higher degree of judgment and complexity, and these assumptions and estimates may significantly affect the consolidated financial statements. Actual results could differ from these estimates and those differences may be material.</span></div>
CY2022	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accounting for Differing Fiscal Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The StepStone Funds primarily have a fiscal year end as of December 31. The Company accounts for its investments in the StepStone Funds on a three-month lag due to the timing of receipt of financial information from the investments held by the StepStone Funds. The StepStone Funds primarily invest in private markets funds that generally require at least 90 days following the calendar year end to provide audited financial statements. As a result, the Company uses the December 31 audited financial statements of the StepStone Funds, which reflect the underlying private markets funds as of December 31 to record its investments (including any carried interest allocated by those investments) for its fiscal year-end consolidated financial statements as of March 31. The Company further adjusts the reported carrying values of its investments in the StepStone Funds for its share of capital contributions to and distributions from the StepStone Funds during the three-month lag period.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company does not account for management and advisory fees or incentive fees on a three-month lag.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that management becomes aware of any material events that affect the StepStone Funds during the three-month lag period, the effect of the events would be disclosed in the notes to the consolidated financial statements.</span></div>
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	66700000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	76900000	USD
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1100000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	600000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1000000.0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022	step	Revenue From Contract With Customer Incentive Fees As Percentage Of Net Investment Income RevenueFromContractWithCustomerIncentiveFeesAsPercentageOfNetInvestmentIncome	0.10
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	3500000	USD
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk or other risks consist principally of cash, cash equivalents, restricted cash, investments and fees receivable. The majority of the Company’s cash, cash equivalents and restricted cash is held in large, high credit quality financial institutions. Substantially all cash amounts on deposit with these large financial institutions exceed federally insured limits; however, based upon an assessment of the financial condition and the reputations of these financial institutions, management believes that the Company’s exposure to credit risk is remote. The concentration of credit risk related to fees receivable is generally reduced by the relatively short payment terms extended to the Company’s clients.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amounts due to the Company in the form of carried interest allocations, which are reported as a component of investments in the consolidated balance sheets, remain subject to investment performance risk. In certain cases, carried interest allocations that have been distributed to the Company may remain subject to clawback, pursuant to the terms of the governing documents of the related funds. Refer to the discussion of carried interest above in this note 2 for additional details regarding the investment performance and clawback risk associated with carried interest allocations that have been recognized in income by the Company and/or recorded as accrued carried interest allocations in the consolidated balance sheets.</span></div>
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	19000000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13900000	USD
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4600000	USD
CY2022Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	107045000	USD
CY2021Q1	step	Equity Method Investments Excluding Accrued Carried Interest Allocations EquityMethodInvestmentsExcludingAccruedCarriedInterestAllocations	74379000	USD
CY2022Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	1480515000	USD
CY2021Q1	step	Equity Method Investments Accrued Carried Interest Allocations EquityMethodInvestmentsAccruedCarriedInterestAllocations	896523000	USD
CY2022Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	1334581000	USD
CY2021Q1	step	Legacy Investments In Funds And Accrued Carried Interest Allocations LegacyInvestmentsInFundsAndAccruedCarriedInterestAllocations	0	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2922141000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	970902000	USD
CY2022Q1	step	Legacy Investments In Funds LegacyInvestmentsInFunds	194500000	USD
CY2022Q1	step	Legacy Accrued Carried Interest Allocations LegacyAccruedCarriedInterestAllocations	1140100000	USD
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26160000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16407000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6926000	USD
CY2022	step	Legacy Investment Income LegacyInvestmentIncome	32586000	USD
CY2021	step	Legacy Investment Income LegacyInvestmentIncome	0	USD
CY2020	step	Legacy Investment Income LegacyInvestmentIncome	0	USD
CY2022	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	1032421000	USD
CY2021	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	513187000	USD
CY2020	step	Revenue Not From Contract With Customer Income Loss From Equity Method Investments And Investment Income RevenueNotFromContractWithCustomerIncomeLossFromEquityMethodInvestmentsAndInvestmentIncome	214922000	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1541000	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1035000	USD
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	17769000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	9600000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1608000	USD
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	885000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	1102000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	28025000	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1541000	USD
CY2022	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	9600000	USD
CY2021	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	1608000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22040000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18875000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9278000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8646000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12762000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10229000	USD
CY2022	us-gaap	Depreciation Depreciation	2500000	USD
CY2021	us-gaap	Depreciation Depreciation	2200000	USD
CY2020	us-gaap	Depreciation Depreciation	2000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	60064000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35567000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	398125000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5491000	USD
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24500000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	43481000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	42645000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	41955000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	41764000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	41730000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	186550000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	398125000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	580500000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	6800000	USD
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2021Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	65000000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2121000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	62879000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2022Q1	step	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVested	1219119	shares
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	41000000	USD
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y6M
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7400000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	471247000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	307396000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	130380000	USD
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	41334000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30453000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	18360000	USD
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	512581000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	337849000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148740000	USD
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13340000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2929000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2714000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1141000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1085000	USD
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6383000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3381000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3041000	USD
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22437000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7451000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4126000	USD
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4897000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14752000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	966000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1074000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-21000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-171000	USD
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5863000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15805000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-171000	USD
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28300000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23256000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3955000	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
CY2022	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.119
CY2021	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.157
CY2020	step	Effective Income Tax Rate Reconciliation Income Passed Through To Limited Partners Percent EffectiveIncomeTaxRateReconciliationIncomePassedThroughToLimitedPartnersPercent	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.012
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.010
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.019
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.053
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.055
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.069
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.026
CY2022Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	39720000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	118165000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1568000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1811000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41288000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	119976000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13422000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30537000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27866000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	89439000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1529000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26337000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	89439000	USD
CY2021Q3	step	Increase Decrease In Deferred Tax Assets IncreaseDecreaseInDeferredTaxAssets	-137400000	USD
CY2021Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-32400000	USD
CY2021Q3	step	Adjustments To Additional Paid In Capital Decrease In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalDecreaseInDeferredTaxAssetsValuationAllowance	5000000	USD
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-27400000	USD
CY2021Q3	step	Increase Decrease In Due To Related Parties Tax Receivable Agreements IncreaseDecreaseInDueToRelatedPartiesTaxReceivableAgreements	93000000	USD
CY2022Q1	step	Due To Related Parties Tax Receivable Agreements DueToRelatedPartiesTaxReceivableAgreements	197200000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13400000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2021	step	Adjustments To Additional Paid In Capital Increase In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInDeferredTaxAssetsValuationAllowance	30537000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30537000	USD
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-27413000	USD
CY2022	step	Adjustments To Additional Paid In Capital Decrease In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalDecreaseInDeferredTaxAssetsValuationAllowance	5006000	USD
CY2022	step	Adjustments To Additional Paid In Capital Increase In Deferred Tax Assets Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInDeferredTaxAssetsValuationAllowance	15304000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13422000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	193885000	USD
	us-gaap	Net Income Loss NetIncomeLoss	62634000	USD
CY2022Q1	step	Number Of Classes Of Common Stock Outstanding NumberOfClassesOfCommonStockOutstanding	2	classOfStock
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	205617000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68411000	USD
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49833760	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29657805	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53600250	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33274804	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.89
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.84
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	19369000	USD
CY2021Q1	us-gaap	Due From Related Parties DueFromRelatedParties	7474000	USD
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	199355000	USD
CY2021Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	113522000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	300000	USD
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	300000	USD
CY2021Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4500000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	51.83
CY2019Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	110800000	USD
CY2019Q3	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2300000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.44
CY2022	step	Business Acquisition Pro Forma Revenue And Unrealized Gains Losses BusinessAcquisitionProFormaRevenueAndUnrealizedGainsLosses	1866986000	USD
CY2021	step	Business Acquisition Pro Forma Revenue And Unrealized Gains Losses BusinessAcquisitionProFormaRevenueAndUnrealizedGainsLosses	1362067000	USD
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	168653000	USD
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	80743000	USD
CY2022	step	Lessee Operating Lease Number Of Cities LesseeOperatingLeaseNumberOfCities	23	city
CY2021Q2	step	Lessee Operating Lease Lease Not Yet Commenced Total Lease Payments Due LesseeOperatingLeaseLeaseNotYetCommencedTotalLeasePaymentsDue	3300000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P9Y
CY2022Q1	step	Lessee Operating Lease Lease Not Yet Commenced Total Lease Payments Due LesseeOperatingLeaseLeaseNotYetCommencedTotalLeasePaymentsDue	21700000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P10Y
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	11098000	USD
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	957000	USD
CY2022	us-gaap	Sublease Income SubleaseIncome	1679000	USD
CY2022	us-gaap	Lease Cost LeaseCost	10376000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9300000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8700000	USD
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	10319000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y8M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.027
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10861000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11582000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10545000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10227000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9252000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	29602000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	82069000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11104000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	70965000	USD
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	68200000	USD
CY2021Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	60500000	USD
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	68200000	USD
CY2022Q1	step	Equity Method Investment Carried Interest Allocations Maximum Amount Subject To Contingent Repayment EquityMethodInvestmentCarriedInterestAllocationsMaximumAmountSubjectToContingentRepayment	204800000	USD
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4300000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3200000	USD
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	900000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2700000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	23800000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	21700000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-2200000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-3800000	USD
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1100000	USD
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	400000	USD

Files In Submission

Name	View Source	Status
0001796022-22-000029-index-headers.html	Edgar Link	pending
0001796022-22-000029-index.html	Edgar Link	pending
0001796022-22-000029.txt	Edgar Link	pending
0001796022-22-000029-xbrl.zip	Edgar Link	pending
exhibit211-subsidiarieslis.htm	Edgar Link	pending
exhibit231consentofeyq4fy2.htm	Edgar Link	pending
exhibit311q4fy2022.htm	Edgar Link	pending
exhibit312q4fy2022.htm	Edgar Link	pending
exhibit321q4fy2022.htm	Edgar Link	pending
exhibit322q4fy2022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
step-20220331.htm	Edgar Link	pending
step-20220331.xsd	Edgar Link	pending
step-20220331_cal.xml	Edgar Link	unprocessable
step-20220331_def.xml	Edgar Link	unprocessable
step-20220331_g1.jpg	Edgar Link	pending
step-20220331_g2.jpg	Edgar Link	pending
step-20220331_g3.jpg	Edgar Link	pending
step-20220331_htm.xml	Edgar Link	completed
step-20220331_lab.xml	Edgar Link	unprocessable
step-20220331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STEP
StepStone Group Inc. Stock $step

2022 Q1 Form 10-K Financial Statement

#000179602222000029 Filed on May 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STEP StepStone Group Inc. Stock $step

2022 Q1 Form 10-K Financial Statement

#000179602222000029 Filed on May 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STEP
StepStone Group Inc. Stock $step